Vigabatrin
Product manufactured by Cipla Usa, Inc.
Indications and Purposes
| 1 Indications And Usage Vigabatrin For Oral Solution Is Indicated For The Treatment Of: Refractory Complex Partial Seizures As Adjunctive Therapy In Patients 2 Years Of Age And Older Who Have Responded Inadequately To Several Alternative Treatments; Vigabatrin For Oral Solution Is Not Indicated As A First Line Agent ( 1.1 ) Infantile Spasms - Monotherapy In Infants 1 Month To 2 Years Of Age For Whom The Potential Benefits Outweigh The Potential Risk Of Vision Loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (Cps) Vigabatrin For Oral Solution Is Indicated As Adjunctive Therapy For Adults And Pediatric Patients 2 Years Of Age And Older With Refractory Complex Partial Seizures Who Have Inadequately Responded To Several Alternative Treatments And For Whom The Potential Benefits Outweigh The Risk Of Vision Loss [See Warnings And Precautions (5.1) ]. Vigabatrin For Oral Solution Is Not Indicated As A First Line Agent For Complex Partial Seizures. 1.2 Infantile Spasms (Is) Vigabatrin For Oral Solution Is Indicated As Monotherapy For Pediatric Patients With Infantile Spasms 1 Month To 2 Years Of Age For Whom The Potential Benefits Outweigh The Potential Risk Of Vision Loss [See Warnings And Precautions (5.1) ]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Vigabatrin |
|
ZINC403618 |